Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The potential of human embryonic stem (ES) cells to meet the growing demand for cell types and tissues for the treatment of chronic and degenerative diseases has been widely acclaimed. Nevertheless, their use in cell replacement therapy poses a number of significant challenges, not least of which is their subsequent rejection by the recipient's immune system. Here we explore the extent of the immunological barriers encountered and evaluate the potential of different approaches to overcoming these issues of which somatic nuclear transfer (SNT) and the induction of transplanation tolerance are currently the most promising.

Original publication

DOI

10.1385/SCR:1:2:159

Type

Journal article

Journal

Stem Cell Rev

Publication Date

2005

Volume

1

Pages

159 - 167

Keywords

Animals, Cell- and Tissue-Based Therapy, Dendritic Cells, Embryonic Stem Cells, Humans, Immunity, Stem Cell Transplantation